Literature DB >> 8237747

Short- and long-term neurohormonal activation following acute myocardial infarction.

A Sigurdsson1, P Held, K Swedberg.   

Abstract

Plasma levels of atrial natriuretic peptide (ANP), angiotensin II, aldosterone, and catecholamines were followed for 1 month and then for 4 to 6 months in 55 patients with acute myocardial infarction. Plasma hormones were highest within the first 24 hours after the onset of infarction but normalized during the first few days in patients without heart failure. In patients with symptoms of heart failure, angiotensin II and norepinephrine remained elevated for 1 month and ANP remained elevated for 4 to 6 months. During head-up tilt, angiotensin II and norepinephrine increased most in patients with overt heart failure. Among patients with a first myocardial infarction, a positive correlation was found between infarct size and ANP, angiotensin II, and norepinephrine on day 5 to 7 and between infarct size and angiotensin II during head-up tilt at 1 month, and between infarct size and ANP at 1 month. A similar relationship was found when only patients without heart failure were studied. It is concluded that sustained neurohormonal activation after myocardial infarction mainly occurs in patients with clinical heart failure but is related to the magnitude of myocardial damage, even in patients without heart failure. Measurement of neurohormones during head-up tilt may be an additive assessment for the detection of neurohormonal activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8237747     DOI: 10.1016/0002-8703(93)90656-t

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  30 in total

1.  Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarction.

Authors:  J T Walsh; P D Batin; M Hawkins; D McEntegart; A J Cowley
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

2.  Plasma catecholamines and ischemic heart disease.

Authors:  Jana Slavíková; Jitka Kuncová; Ondrej Topolcan
Journal:  Clin Cardiol       Date:  2007-07       Impact factor: 2.882

3.  Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model.

Authors:  D L Jardine; C J Charles; R K Ashton; S I Bennett; M Whitehead; C M Frampton; M G Nicholls
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

4.  Outcomes of correcting hyponatremia in patients with myocardial infarction.

Authors:  Waqas Qureshi; Syed Hassan; Fatima Khalid; Mohamed Faher Almahmoud; Bhavik Shah; Ra'ad Tashman; Nikhil Ambulgekar; Mostafa El-Refai; Chetan Mittal; Zaid Alirhayim
Journal:  Clin Res Cardiol       Date:  2013-05-08       Impact factor: 5.460

Review 5.  The renin-angiotensin-aldosterone system and cardiac ischaemia.

Authors:  H Ikram
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 6.  Neuroendocrine activation after myocardial infarction: causes and consequences.

Authors:  J G Cleland; P J Cowburn; K Morgan
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 7.  Effects of exercise training on neurovascular control and skeletal myopathy in systolic heart failure.

Authors:  Carlos E Negrao; Holly R Middlekauff; Igor L Gomes-Santos; Ligia M Antunes-Correa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

Review 8.  Neuroendocrine System Regulatory Mechanisms: Acute Coronary Syndrome and Stress Hyperglycaemia.

Authors:  Ricardo A Perez de la Hoz; Sandra Patricia Swieszkowski; Federico Matias Cintora; Jose Martin Aladio; Claudia Mariana Papini; Maia Matsudo; Alejandra Silvia Scazziota
Journal:  Eur Cardiol       Date:  2018-08

9.  CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis.

Authors:  Toshimitsu Okuda; Norimasa Yoshida; Tomohisa Takagi; Osamu Handa; Satoshi Kokura; Hiroshi Ichikawa; Yuji Naito; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

10.  Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease.

Authors:  James N Tsoporis; Forough Mohammadzadeh; Thomas G Parker
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.